Sphingotec's Critical Care Biomarkers Early Diagnose Risk of Loss of Endothelial, Kidney and Heart Function in Severely Ill COVID-19 Patients Results of a consensus meeting of clinical experts investigating sphingotec's diagnostic solutions for acute and critical care in COVID-19.... JUNE 18, 2020 • YAHOO.COM
